Emergent Biosolutions(EBS.US)

Last Updated 19:00:00 ET
longbridge loading

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live] | EBS Stock News

StockTitan·
US
EBS
-0.86%
StockTitan·
US
EBS
-0.86%

Emergent BioSolutions Shares Turnaround Update at 2026 Annual Meeting; All Proposals Approved

Market Beat·
US
EBS
-0.86%
US
PBE
+0.11%
US
IBBQ
+0.07%
Market Beat·
US
EBS
-0.86%
US
PBE
+0.11%
US
IBBQ
+0.07%

Emergent BioSolutions Earnings Call Highlights Turnaround Momentum

Tip Ranks·
US
EBS
-0.86%
US
FBT
+0.54%
US
IBBQ
+0.07%
Tip Ranks·
US
EBS
-0.86%
US
FBT
+0.54%
US
IBBQ
+0.07%

Riot Platforms Q1 2026 Earnings Call: Complete Transcript

benzinga_article·
US
RIOT
-2.31%
US
GBTC
-0.10%
US
BTF
-0.35%
benzinga_article·
US
RIOT
-2.31%
US
GBTC
-0.10%
US
BTF
-0.35%

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga_article·
US
CUE
-5.05%
US
EBS
-0.86%
US
SHPH
-1.77%
benzinga_article·
US
CUE
-5.05%
US
EBS
-0.86%
US
SHPH
-1.77%

Emergent BioSolutions shares are trading higher after the company reported better-than-expected Q1 financial results.

benzinga_article·
US
EBS
-0.86%
US
IBB
+0.10%
US
PBE
+0.11%
benzinga_article·
US
EBS
-0.86%
US
IBB
+0.10%
US
PBE
+0.11%

Emergent BioSolutions Reports First Quarter 2026 Financial Results

Unusual Whales·
US
EBS
-0.86%
US
FBT
+0.54%
US
XBI
-0.69%
Unusual Whales·
US
EBS
-0.86%
US
FBT
+0.54%
US
XBI
-0.69%

Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox | EBS Stock News

StockTitan·
US
EBS
-0.86%
StockTitan·
US
EBS
-0.86%
© 2026 Longbridge｜Disclaimer